RecallDepth
Class II Terminated

Clozapine Orally Disintegrating Tablets, 12.5 mg, 100-count bottles, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5416-01 Yellow, round, flat-faced, beveled-edge, unscored tablet. Debossed with 13 on one side and plain on the other side.

Company
Teva Pharmaceuticals Usa
Recall Initiated
September 21, 2018
Posted
October 10, 2018
Recall Number
D-0001-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
313 bottles
Firm Location
North Wales, PA, United States

Reason for Recall

Failed Disintegration Specifications: Out-of-specification disintegration test result obtained during routine stability testing.

Distribution

Distributed nationwide in the USA

Lot / Code Info

Lot #: 34034024B, Exp 02/20

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls